• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康出生队列中两种不同免疫接种方案对 10 价肺炎球菌结合疫苗的唾液抗体反应。

Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.

机构信息

Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, Netherlands.

Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands; Department of Paediatrics, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands.

出版信息

Vaccine. 2022 Jan 24;40(3):408-413. doi: 10.1016/j.vaccine.2021.12.013. Epub 2021 Dec 24.

DOI:10.1016/j.vaccine.2021.12.013
PMID:34961634
Abstract

Pneumococcal conjugate vaccines reduce pneumococcal colonization via serotype-specific immunoglobulin G (IgG) at mucosal surfaces. The infant immunization schedule with the ten-valent pneumococcal conjugate vaccine (PCV10) changed from a 3 + 1 schedule (2-3-4-11 months) to a 2 + 1 schedule (2-4-11 months) in The Netherlands in 2013. We compared anti-pneumococcal IgG concentrations in saliva between the schedules. IgG was measured using a fluorescent bead-based multiplex immunoassay at the ages of 6 (post-primary) and 12 (post-booster) months in 51 infants receiving the 3 + 1 schedule and 68 infants receiving the 2 + 1 schedule. Post-primary IgG geometric mean concentrations (GMCs) were comparable between schedules for all vaccine serotypes. Post-booster IgG GMCs were significantly lower after the 2 + 1 schedule for serotypes 4 (p = 0.035), 7F (p = 0.048) and 23F (p = 0.0056). This study shows small differences in mucosal IgG responses between a 3 + 1 and a 2 + 1 PCV10 schedule. Future studies should establish correlates of protection against pneumococcal colonization for mucosal antibodies.

摘要

肺炎球菌结合疫苗通过黏膜表面的血清型特异性免疫球蛋白 G(IgG)减少肺炎球菌定植。2013 年,荷兰将十价肺炎球菌结合疫苗(PCV10)的婴儿免疫接种计划从 3+1 方案(2-3-4-11 个月)改为 2+1 方案(2-4-11 个月)。我们比较了两种方案中唾液中的抗肺炎球菌 IgG 浓度。在 51 名接受 3+1 方案和 68 名接受 2+1 方案的婴儿中,在 6 个月(初免后)和 12 个月(加强后)龄时,使用荧光珠基多重免疫分析测定 IgG。对于所有疫苗血清型,两种方案的初免后 IgG 几何平均浓度(GMC)相似。在 2+1 方案后,血清型 4(p=0.035)、7F(p=0.048)和 23F(p=0.0056)的 IgG 增强后 GMC 显著降低。本研究表明,3+1 和 2+1 PCV10 方案之间黏膜 IgG 反应存在微小差异。未来的研究应该确定针对黏膜抗体的肺炎球菌定植保护相关性。

相似文献

1
Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.健康出生队列中两种不同免疫接种方案对 10 价肺炎球菌结合疫苗的唾液抗体反应。
Vaccine. 2022 Jan 24;40(3):408-413. doi: 10.1016/j.vaccine.2021.12.013. Epub 2021 Dec 24.
2
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.10价或13价肺炎球菌结合疫苗在荷兰婴儿11个月龄加强免疫前后诱导的免疫原性的直接比较
PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015.
3
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial.南非儿童中一剂与两剂基础免疫序贯加强一剂 10 价或 13 价肺炎球菌结合疫苗的免疫原性比较:一项开放标签、随机、非劣效性试验。
Lancet Infect Dis. 2020 Dec;20(12):1426-1436. doi: 10.1016/S1473-3099(20)30289-9. Epub 2020 Aug 25.
4
Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.根据 4 种不同的基础免疫方案在婴儿中接种 13 价肺炎球菌结合疫苗的免疫原性:一项随机临床试验。
JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.
5
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial.两种两剂次免疫程序的十价肺炎球菌结合疫苗在尼泊尔儿童中的比较:一项开放性、随机、非劣效对照试验。
Lancet Infect Dis. 2019 Feb;19(2):156-164. doi: 10.1016/S1473-3099(18)30568-1. Epub 2019 Jan 8.
6
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.越南胡志明市婴幼儿接种 10 价与 13 价肺炎球菌结合疫苗的免疫原性和反应原性:一项随机对照试验。
Lancet Infect Dis. 2019 May;19(5):497-509. doi: 10.1016/S1473-3099(18)30734-5. Epub 2019 Apr 8.
7
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.10 价肺炎球菌结合疫苗在冈比亚健康婴儿中按照 2+1 程序接种的免疫原性和安全性:一项单中心、双盲、主动对照、随机、3 期临床试验。
Lancet Infect Dis. 2023 May;23(5):609-620. doi: 10.1016/S1473-3099(22)00734-4. Epub 2023 Jan 10.
8
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.两种剂量初免加 9 个月加强免疫与标准三剂初免方案用于尼泊尔婴儿的 10 价肺炎球菌结合疫苗的比较:一项随机、对照、开放标签、非劣效性试验。
Lancet Infect Dis. 2015 Apr;15(4):405-14. doi: 10.1016/S1473-3099(15)70007-1. Epub 2015 Feb 18.
9
Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial.越南胡志明市婴幼儿中不同十价肺炎球菌结合疫苗接种程序的免疫原性:一项单盲、平行分组、开放性、随机、对照试验的结果。
Lancet Infect Dis. 2021 Oct;21(10):1415-1428. doi: 10.1016/S1473-3099(20)30775-1. Epub 2021 Jun 23.
10
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.13 价肺炎球菌结合疫苗作为一剂基础免疫和一剂加强免疫(1+1),与两剂基础免疫和一剂加强免疫(2+1)相比,在英国婴儿中的效果:一项多中心、平行组随机对照试验。
Lancet Infect Dis. 2018 Feb;18(2):171-179. doi: 10.1016/S1473-3099(17)30654-0. Epub 2017 Nov 22.

引用本文的文献

1
Plasma cell disorders supress mucosal anti-bacterial immunity: another dimension of immunoparesis in plasma cell neoplasms.浆细胞疾病抑制黏膜抗菌免疫:浆细胞肿瘤免疫不全的另一个方面。
Leukemia. 2024 Nov;38(11):2501-2504. doi: 10.1038/s41375-024-02398-1. Epub 2024 Sep 7.